Blockchain Registration Transaction Record
Cybin CEO to Speak at Milken Institute Global Conference on Medical Breakthroughs
Cybin Inc. CEO Doug Drysdale to discuss medical breakthroughs at Milken Institute Global Conference. Cybin's innovative approach to mental health treatments showcased. Learn more about the company's proprietary therapies for depression and anxiety.

This news highlights the growing interest in psychedelic-based therapies for mental health issues and showcases Cybin's commitment to innovation in drug development. Investors and individuals following advancements in mental healthcare will find this development significant as it sheds light on the potential for new treatment options in the field.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x5baf11d5b57f5caac3a26b153b597815418fd0b3ee8fde0a79018a1acd24375f |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | maskXw9g-e2a271e1e25f0b027bba247607f2e2b9 |